[1]
2026. FROM SERUM DYSLIPIDEMIA TO MACROPHAGE LIPID REMODELING IN VISCERAL LEISHMANIASIS: CHOLESTEROL TRAFFICKING, IMMUNOMETABOLIC REPROGRAMMING, AND THERAPEUTIC OPPORTUNITIES. ISIR Journal of Business and Management Studies (ISIRJBMS). 3, 5 (Oct. 2026), 45–55.